Help Protect Access to HOMEOPATHIC REMEDIES, Click here to Send a Comment to FDA

NO LONGER ACTIVE – Comment Period Closed

Help Protect Access to
HOMEOPATHIC REMEDIES
Send a Comment to FDA by Clicking Below
Comment Deadline January 23, 2020!

 

Please oppose the revised Draft Guidance FDA recently proposed for “Drugs Labeled as Homeopathic.”  If this Guidance is finalized, it will jeopardize consumer access to a number of excellent homeopathic remedies now used by consumers. 

Take Action Here to submit your own comment to the FDA online, a quick and effective way to let FDA know you are in opposition and why.

Take Action Here to send a letter to your Congressional Representatives asking them to submit opposition comments to the FDA too.

Read NHFA’s Comments Here.  NHFA has reviewed the revised Draft Guidance and submitted a formal comment opposing the Draft Guidance.  There are three key reasons why we oppose the draft guidance: 

      1.  The FDA draft Guidance could result in less homeopathic remedies being available to consumers and all Americans.

  1. The FDA has repealed a historic guidance documents (CPG 400.400)that has for decades acknowledged and protected the unique nature of homeopathic remedies.
  2. In addition, FDA is now attempting to establish enforcement priorities for homeopathic remedies similar to all other pharmaceutical drug unapproved drugs,based on a general “risk-based” approach, without acknowledgement of homeopathic drugs’ safety and unique qualities of high dilution, succession, and energy medicine, and the FDA has even added restrictions not imposed on pharmaceutical unapproved drugs 

Take Action Here and ask FDA to honor and protect access to all homeopathic remedies.